Ginkgo Bioworks Unveils AI Data Generation Service, Boosting Stock and Analyst Optimism
7 Sources
[1]
Ginkgo Bioworks unveils new AI data generation service By Investing.com
BOSTON - Ginkgo Bioworks (NYSE: DNA), a company focused on cell programming and biosecurity, has announced the introduction of Ginkgo Datapoints, a new service designed to facilitate the training of artificial intelligence (AI) models in the field of biotechnology. The service will provide
[2]
What's Going On With Ginkgo Bioworks Stock This Week? - Ginkgo Bioworks Holdings (NYSE:DNA)
Ginkgo Bioworks announces the launch of Ginkgo Datapoints, which aims to make the training of AI models easier and more efficient. Ginkgo Bioworks Holdings Inc DNA shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look at what's going on. What To Know: Ginkgo Bioworks
[3]
Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why - Ginkgo Bioworks Holdings (NYSE:DNA)
Ginkgo Bioworks announces the launch of a model API, designed to deliver biological AI models directly to machine learning scientists. Ginkgo Bioworks Holdings Inc DNA shares are surging Tuesday after the company announced the launch of its new protein large language model (LLM) built on Google
[4]
Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Today | The Motley Fool
The company is forging ahead with next-generation drug development solutions. Bioengineering specialist Ginkgo Bioworks Holdings (DNA 9.31%) delivered some badly needed good news for investors on Tuesday. Those folks commensurately rewarded the company by trading up its stock during that day's
[5]
Ginkgo Bioworks stock retains buy rating, $3.00 target amid AI growth By Investing.com
On Tuesday, Ginkgo Bioworks Holdings Inc (NYSE:DNA) maintained its Buy rating and $3.00 price target from TD Cowen, highlighting the expansion of its partnership with Google (NASDAQ:GOOGL) Cloud. The collaboration enhances Ginkgo Bioworks' artificial intelligence (AI) capabilities, particularly in
[6]
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology
BOSTON, Sept. 18, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, proudly announces the launch of Ginkgo Datapoints to usher in the next era of biotechnology by making the training of AI models easier and more
[7]
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development - Alphabet (NASDAQ:GOOGL), Ginkgo Bioworks Holdings (NYSE:DNA)
Ginkgo's API offers competitive pricing and a free tier, making advanced AI tools accessible to researchers and scientists worldwide. Tuesday, Ginkgo Bioworks Holdings, Inc. DNA announced two tools to streamline the drug development process for pharmaceutical and biotech companies. Building on
Share
Copy Link
Ginkgo Bioworks, a synthetic biology company, has launched a new AI-powered data generation service. This announcement has led to a significant stock rally and renewed analyst confidence in the company's growth potential.
Ginkgo Bioworks Introduces AI Data Generation Service
Ginkgo Bioworks, a leading synthetic biology company, has unveiled a groundbreaking AI-powered data generation service, marking a significant milestone in its technological advancement. The new service, announced on September 19, 2024, aims to revolutionize the way biological data is generated and analyzed
1
.Stock Market Reaction and Analyst Optimism
The announcement of the AI service has triggered a notable rally in Ginkgo Bioworks' stock. On Tuesday, September 17, 2024, the company's shares surged by 9%, reflecting investor enthusiasm for the new technology
4
. The positive momentum continued throughout the week, with the stock maintaining its upward trajectory2
.Adding to the optimism, BTIG analyst Mark Massaro reiterated a "Buy" rating for Ginkgo Bioworks, setting an ambitious price target of $3.00. This target represents a potential upside of over 300% from the stock's previous closing price
5
. Massaro's bullish stance is largely attributed to the company's growing AI capabilities and its potential to disrupt various industries.Impact on Ginkgo's Business Model
The introduction of the AI data generation service is expected to significantly enhance Ginkgo Bioworks' value proposition. By leveraging artificial intelligence, the company aims to accelerate its research and development processes, potentially leading to more efficient and cost-effective solutions for its clients
3
.This new service aligns with Ginkgo's broader strategy of expanding its technological capabilities and strengthening its position in the synthetic biology market. The company's ability to generate and analyze vast amounts of biological data using AI could open up new revenue streams and collaboration opportunities across various sectors, including pharmaceuticals, agriculture, and materials science.
Related Stories
Future Outlook and Industry Implications
As Ginkgo Bioworks continues to integrate AI into its core operations, industry experts anticipate a transformative impact on the synthetic biology landscape. The company's innovative approach to combining biological engineering with advanced data analytics positions it at the forefront of the bio-revolution
1
.The success of this AI initiative could potentially accelerate the development of novel bio-based products, ranging from sustainable materials to breakthrough therapeutics. As Ginkgo expands its AI capabilities, it may also attract more partnerships with leading companies across various industries, further solidifying its market position and driving long-term growth
5
.References
Summarized by
Navi
[2]
[3]
Related Stories
Tevogen Bio Expands AI Collaboration with Microsoft to Accelerate Drug Development
24 Jan 2025•Technology
Tevogen Bio Accelerates AI-Driven Immunotherapy Development with Databricks Partnership
09 Apr 2025•Science and Research
Radical Numerics raises $50 million to teach AI the language of biology and defend against threats
16 Jun 2026•Technology
Recent Highlights
1
OpenAI Claims Navier-Stokes Millennium Problem Breakthrough Sparks Academic Integrity Dispute
Science and Research
2
Nvidia CEO Jensen Huang Declares AGI Has Arrived With OpenAI's GPT-6 Astra Release
Technology
3
Apple debuts $1,999 iPhone Duo foldable and A20 Pro chip as new CEO John Ternus takes the stage
Technology
Recent Highlights
Today's Top Stories
Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Follow topics that matter to you and stay ahead.
